Symptom improvement was not significantly associated with weight loss, dose, or treatment duration in women with lipoedema treated with tirzepatide: a retrospective cohort study of prospectively collected outcomes.

Pinto da Costa Viana D, Invitti AL, Schor E

Open source

DOI
10.1016/j.metop.2026.100518
Published
2026 Dec
Container
Metabolism open
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.metop.2026.100518,
  title = {Symptom improvement was not significantly associated with weight loss, dose, or treatment duration in women with lipoedema treated with tirzepatide: a retrospective cohort study of prospectively collected outcomes.},
  author = {Pinto da Costa Viana D and Invitti AL and Schor E},
  year = {2026},
  journal = {Metabolism open},
  doi = {10.1016/j.metop.2026.100518},
  url = {https://doi.org/10.1016/j.metop.2026.100518}
}

RIS

TY  - JOUR
TI  - Symptom improvement was not significantly associated with weight loss, dose, or treatment duration in women with lipoedema treated with tirzepatide: a retrospective cohort study of prospectively collected outcomes.
AU  - Pinto da Costa Viana D
AU  - Invitti AL
AU  - Schor E
PY  - 2026
JO  - Metabolism open
DO  - 10.1016/j.metop.2026.100518
UR  - https://doi.org/10.1016/j.metop.2026.100518
ER  - 

APA

D, P. D. C. V., AL, I., & E, S. (2026). Symptom improvement was not significantly associated with weight loss, dose, or treatment duration in women with lipoedema treated with tirzepatide: a retrospective cohort study of prospectively collected outcomes.. Metabolism open. https://doi.org/10.1016/j.metop.2026.100518

Source records